echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Upstream and Downstream products of 5-Amino-1-chloroisoquinoline

    The Upstream and Downstream products of 5-Amino-1-chloroisoquinoline

    • Last Update: 2023-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    5-Amino-1-chloroisoquinoline, also known as 5-CIQ, is a chemical compound that is commonly used in the pharmaceutical and chemical industries.
    The compound is classified as an antioxidant and is often used as a intermediate for the production of various drugs and chemicals.


    Upstream and Downstream Products of 5-Amino-1-chloroisoquinoline


    The production of 5-Amino-1-chloroisoquinoline involves several steps, including the synthesis of the base compound and its subsequent processing into the final product.
    The upstream products of 5-Amino-1-chloroisoquinoline include the raw materials required for its synthesis, such as chloroacetamide and ammonia.
    The downstream products of 5-Amino-1-chloroisoquinoline include the final product, which can be used as an intermediate for the production of various drugs and chemicals.


    One of the most common downstream products of 5-Amino-1-chloroisoquinoline is the production of antioxidants.
    The compound is used as a precursor for the synthesis of various antioxidants, which are commonly used in the pharmaceutical and cosmetic industries.
    Antioxidants are compounds that are capable of neutralizing the harmful effects of free radicals in the body, and they are often used to prevent or treat a range of diseases, including cancer and cardiovascular disease.


    Another downstream product of 5-Amino-1-chloroisoquinoline is the production of anti-inflammatory drugs.
    The compound is used as a precursor for the synthesis of various anti-inflammatory drugs, which are commonly used to treat pain and inflammation associated with conditions such as arthritis and gout.


    5-Amino-1-chloroisoquinoline is also used in the production of other pharmaceuticals, such as analgesics and anti-cancer drugs.
    The compound is often used as a precursor for the synthesis of these drugs, which are used to treat a range of diseases, including cancer and pain.


    In addition to its use in the pharmaceutical industry, 5-Amino-1-chloroisoquinoline is also used in the chemical industry.
    The compound is used as a catalyst for various chemical reactions and is often used in the production of plastics and other synthetic materials.


    Overall, 5-Amino-1-chloroisoquinoline is a versatile compound that is widely used in the pharmaceutical and chemical industries.
    Its ability to serve as a precursor for the synthesis of various drugs and chemicals has made it an essential component in the production of many modern pharmaceuticals and chemicals.
    As such, it is an important compound that is likely to continue to play a vital role in these industries in the years to come.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.